Cvs drugs new
-
Upload
fred-ecaldre -
Category
Health & Medicine
-
view
725 -
download
4
Transcript of Cvs drugs new
![Page 1: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/1.jpg)
Cardiovascular Cardiovascular DrugsDrugs
Dra. Hena W. Alcantara
![Page 2: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/2.jpg)
The Cardiovascular SystemThe Cardiovascular System
• Heart
• Blood
• Blood Vessels– Arteries
– Veins
– Capillaries
![Page 3: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/3.jpg)
The HeartThe Heart
![Page 4: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/4.jpg)
BloodBlood
![Page 5: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/5.jpg)
Blood VesselsBlood Vessels
![Page 6: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/6.jpg)
CirculationCirculation
![Page 7: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/7.jpg)
![Page 8: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/8.jpg)
In simple terms…In simple terms…
• The heart is a pump.• It pumps blood through a system of
blood vessels that has a limited volume capacity.
• An electric conduction system maintains regular rate and rhythm.
• Myocardial cells require oxygen.
![Page 9: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/9.jpg)
MalfunctionsMalfunctionswhen the heart can no longer pump enough blood to meet the metabolic demands of the body
HEART FAILURE
when blood volume is great compared to the space available inside blood vessels
HYPERTENSION
![Page 10: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/10.jpg)
MalfunctionsMalfunctions
when the electrical conduction pathways malfunction
ARRHYTHMIA
the heart’s way of signaling that some of the cells are not getting enough oxygen
ANGINA
![Page 11: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/11.jpg)
MalfunctionsMalfunctions
when oxygen-starved areas of the heart begin dying
MYOCARDIAL INFARCTION
when you broke with someone…
![Page 12: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/12.jpg)
Cardiovascular DrugsCardiovascular Drugs
![Page 13: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/13.jpg)
Cardiovascular DrugsCardiovascular Drugs
• Anti-hypertensives
• Drugs for Heart Failure
• Anti-anginal and Drugs for MI
• Anti-arrhythmic Agents
![Page 14: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/14.jpg)
Anti-Hypertensive DrugsAnti-Hypertensive Drugs
![Page 15: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/15.jpg)
Physiology of BP RegulationPhysiology of BP Regulation
• Hydraulic Equation:
BP = CO x TPR
![Page 16: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/16.jpg)
BloodPressure
HeartRate
Low Blood PressureLow Blood VolumeNa+ depletion
Angiotensin I
Sympathetic AdrenergicSympathetic AdrenergicSystemSystem
PituitaryGland
Na+& H2OReabsorption
Aldosterone
BloodVolume
Rises
VenousReturn
x
StrokeVolumex
Renin – Renin – AngiotensinAngiotensin
SystemSystem
Angiotensin II
ACE
vasoconstriction
=
Factors that alter the Blood Pressure EquationFactors that alter the Blood Pressure Equation
Kidney
Renin
CardiacOutput
Total PeripheralArterial Resistance
![Page 17: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/17.jpg)
Determinants of Blood Determinants of Blood PressurePressure• Cardiac Output (CO)
– volume of blood pumped out by the heart in 1 minute
– approximately 2.2 – 3.5 L / min / m2 BSA
– determined by Stroke Volume (SV) and Heart Rate (HR)
![Page 18: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/18.jpg)
• Stroke Volume (SV)– volume of blood pumped out by the
heart in every contraction
– determined by:• Inotropic activity –strength of cardiac
contraction• Venous return – cardiac preload; amount of
blood delivered to the heart from the veins; affected by the tone of the veins
Determinants of Blood Determinants of Blood PressurePressure
![Page 19: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/19.jpg)
• Heart Rate (HR)– speed of heart contraction– chronotropism
• Fluid Content of the Blood• Total Peripheral Resistance (TPR)
– resistance or pressure encountered by the heart as it pumps out blood into the peripheral circulation (cardiac afterload)
– determined by the arterioles
Determinants of Blood Determinants of Blood PressurePressure
![Page 20: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/20.jpg)
Mechanisms of BP Mechanisms of BP RegulationRegulation• Baroreceptor Reflex Arch Mechanism
– aka: Postural Reflex Mechanism– moment-to-moment BP regulation
• Baroreceptor – a type of sensory nerve ending found in the walls of the atria of the heart, the vena cava, the aortic arch, and the carotid sinus that is stimulated by changes in pressure
• Renin Angiotensin Aldosterone System
![Page 21: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/21.jpg)
Angiotensinogen (from the liver) Renin
Angiotensin I (inactive)
Angiotensin Converting Enzyme (ACE) or
Peptidyl dipeptidase (majority found in the lungs)
Angiotensin II (active)
-direct vasoconstriction-stimulates synthesis & release of Epi & NE-stimulates the synthesis & release of aldosterone
Renin Angiotensin Aldosterone Renin Angiotensin Aldosterone System (RAAS)System (RAAS)
![Page 22: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/22.jpg)
HypertensionHypertension
![Page 23: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/23.jpg)
HypertensionHypertension
• persistent or recurrent elevation of BP defined as having a:– Systolic reading > 140 mmHg
– Diastolic reading > 90 mmHg
– BP > 140/90
• most common cardiovascular disorder
![Page 24: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/24.jpg)
HypertensionHypertension
• Systole– the period during which the ventricles
are contracting
• Diastole– the period during which the ventricles
are relaxed and filling with blood
![Page 25: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/25.jpg)
HypertensionHypertension• Essential (Primary, Idiopathic)
– hypertension with no identifiable cause– accounts for > 90% of HTNsive cases
• Secondary – resulting from identifiable causes
• kidney diseases • adrenal cortical disorders• pheochromocytoma (adrenal medulla tumor)• coarctation of the aorta• drugs such as steroids, sympathomimetics, contraceptives
– treat the underlying cause– accounts for ~ 10% of HTNsive cases
![Page 26: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/26.jpg)
Classification of BP based on the 7Classification of BP based on the 7 thth Report of the Report of the Joint National Committee on Detection, Evaluation Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VII)and Treatment of High Blood Pressure (JNC VII)
Classification of Blood Pressure (JNC VII)
Systolic BP, mm Hg Diastolic BP, mm
Hg
Normal <120 and <80
Prehypertension 120-139 or 80-89
Stage 1 hypertension 140-159 or 90-99
Stage 2 hypertension >160 or >100
Adapted from JNC VII
![Page 27: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/27.jpg)
Hypertensive EmergencyHypertensive Emergency
• aka: Hypertensive Crisis
• rare, but life-threatening situation
• systolic pressure > 210 mm Hg
• diastolic pressure > 150 mm Hg
![Page 28: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/28.jpg)
Risk FactorsRisk Factors• Family history • Patient history • Racial predisposition
– More common in blacks
• Obesity• Smoking• Stress• High dietary intake
– Saturated fats and sodium
• Sedentary lifestyle• DM• Hyperlipidemia• Gender – males• Age > 60• Postmenopausal
women
![Page 29: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/29.jpg)
Treatment GoalsTreatment Goals
• Rule out uncommon secondary causes of hypertension• Determine the presence and extent of target organ damage• Determine the presence of other CV risk factors• To lower BP with minimal side effects
![Page 30: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/30.jpg)
ComplicationsComplications
• Cardiac effects– Increased oxygen requirements angina pectoris;
because of atherosclerosis angina, MI, sudden death
• Renal effects– Increased blood volume; renal parenchymal damage due
to atherosclerosis
• Cerebral effects– Transient ischemic attacks, cerebral thromboses,
aneurysms with hemorrhage
• Retinal effects– Visual defects (blurred vision, spots, blindness)
![Page 31: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/31.jpg)
TreatmentTreatment
• First line: diuretics (thiazides) and beta blockers
• Alternatives: ACE inhibitors, ARBs, alpha blockers, calcium-channel blockers for px who cannot tolerate first line agents
• Monitor: – blood pressure routinely– observe adverse effects
• Patient Counseling:– Importance of compliance make px realize seriousness
of noncompliance
![Page 32: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/32.jpg)
Anti-hypertensivesAnti-hypertensives
• Diuretics
• Sympathoplegics
• Vasodilators
• Calcium Channel Blockers (CCBs)
• ACE Inhibitors
• Angiotensin II Receptor Blockers (ARBs)
![Page 33: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/33.jpg)
![Page 34: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/34.jpg)
DiureticsDiuretics
• agents that cause urinary loss of Na+ and H2O
• Gen MOA: act on their specific sites in the renal tubule
![Page 35: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/35.jpg)
Five major classesFive major classes
1. Thiazides and thiazide-like
2. Loop diuretics
3. Potassium-sparing
4. Carbonic anhydrase inhibitors
5. Osmotic diuretics
![Page 36: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/36.jpg)
Renal TubuleRenal Tubule
![Page 37: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/37.jpg)
Carbonic Anhydrase Carbonic Anhydrase InhibitorsInhibitors• MOA: inhibit carbonic anhydrase (the
enzyme that catalyzes the reaction of CO2 and H2O leading to H+ and HCO3
-) that can lead to the spillage of Na+ causing diuresis.
• act on the proximal convoluted tubule (PCT)
![Page 38: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/38.jpg)
Carbonic Anhydrase Carbonic Anhydrase InhibitorsInhibitors• Acetazolamide
• Brinzolamide
• Dorzolamide
![Page 39: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/39.jpg)
Carbonic Anhydrase Carbonic Anhydrase InhibitorsInhibitors• limited diuretic effect (2 to 3 days)
• SE: metabolic acidosis, bone marrow depression (sulfonamide-like toxicity), allergic reactions (Stevens-Johnson’s Syndrome)
![Page 40: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/40.jpg)
![Page 41: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/41.jpg)
Loop DiureticsLoop Diuretics
• aka: High Ceiling Diuretics
• high ceiling (most efficacious) as compared with other diuretics
• act on the thick ascending Loop of Henle
![Page 42: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/42.jpg)
Loop DiureticsLoop Diuretics
• MOA: inhibit the Cl-Na-K-cotransporter at the thick ascending LOH
• Furosemide• Bumetanide• Torsemide• Ethacrynic acid
![Page 43: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/43.jpg)
Loop DiureticsLoop Diuretics
• for px who cannot tolerate thiazides, have renal impairment, or ineffectiveness of thiazides
• SE: hypovolemia, ototoxicity, increase serum creatinine
• DI: their efficacy can be reduced by NSAIDs
![Page 44: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/44.jpg)
Loop DiureticsLoop Diuretics
• Side-effects–Hypokalemia
–Bicarbonate is lost in the urine
–INCREASED calcium excretion Hypocalcemia
–Ototoxicity• due to the electrolyte imbalances
![Page 45: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/45.jpg)
Thiazide DiureticsThiazide Diuretics
• MOA: inhibit Na-Cl-cotransporter at the distal convoluted tubule
• Chlorothiazide
• Hydrochlorothiazide
• Chlorthalidone
• Indapamide
![Page 46: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/46.jpg)
![Page 47: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/47.jpg)
Thiazide DiureticsThiazide Diuretics
• first-line drug for uncomplicated hypertension as recommended by JNC 7
• effective initial therapy together with beta-blockers
• also used for Nephrogenic Diabetes Insipidus
![Page 48: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/48.jpg)
Thiazide DiureticsThiazide Diuretics
• SE: hypokalemia, hyponatremia, hyperuricemia, hyperglycemia, hyperlipidemia
• DI: their efficacy can be reduced by NSAIDs
![Page 49: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/49.jpg)
ThiazideThiazide
• Side effects–Hypokalemia
–DECREASED calcium excretion hypercalcemia
–DECREASED uric acid secretion hyperuricemia
–Hyperglycemia
![Page 50: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/50.jpg)
Potassium-Sparing DiureticsPotassium-Sparing Diuretics
• MOA: act in the collecting tubule by inhibiting Na+ reabsorption, K+ secretion and H+ secretion
• Spironolactone• Eprenolone• Amiloride• Triamterene
![Page 51: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/51.jpg)
Potassium-Sparing DiureticsPotassium-Sparing Diuretics
• for patients where potassium loss is significant and supplementation is not feasible
• often combined with thiazides potentiation– Amiloride, Spirinolactone, Triamterene
• precautions– Avoid in px with acute renal failure; use with
caution px with impaired renal function
![Page 52: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/52.jpg)
Potassium Rich Foods Potassium Rich Foods
TOPP PNBB’S
![Page 53: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/53.jpg)
• T- Tomatoes• O-Oranges• P- Peaches• P-potatoes• P-Prunes• N-Nuts• B-Banana• B-Broccoli• S-Spinatch
![Page 54: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/54.jpg)
Potassium-Sparing DiureticsPotassium-Sparing Diuretics
• not associated with hypokalemia
• can be given with other diuretics to lessen the risk of hypokalemia
• SE: hyperkalemia, gynecomastia, impotence, sterility
![Page 55: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/55.jpg)
Osmotic DiureticsOsmotic Diuretics
• MOA: increase the osmotic pressure at the proximal convoluted tubule and Loop of Henle preventing water reabsorption
• Mannitol• Sorbitol• Urea
![Page 56: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/56.jpg)
Osmotic DiureticsOsmotic Diuretics
• used to induce forced diuresis
• mostly used to reduce intracranial pressure
• SE: hypernatremia, hypovolemia
![Page 57: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/57.jpg)
Diuretics ComparisonDiuretics ComparisonDiuretic class Major site of action Special Side effect
(s)
1. Carbonic anhydrase inhibitor
Proximal tubule Acidosis
2. Thiazide and thiazide like
Distal tubule Hyperuricemia
Hypokalemia
3. Loop diuretics L p of Henle Hypokalemia
Ototoxicity
4. Potassium sparing
Distal tubule Hyperkalemia
5. Osmotic diuretic
Glomerulus Hypovolemia & hypotension
![Page 58: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/58.jpg)
Diuretics ComparisonDiuretics ComparisonDiuretic class Special Uses
1. Carbonic anhydrase inhibitor
Mountain sickness
Meniere’s disease
2. Thiazide and thiazide like
Nephrolithiasis due to calcium stones
Hypocalcemia
3. Loop diuretics Hypercalcemia
4. Potassium sparing
CHF taking digoxin
5. Osmotic diuretic
Increased ICP
LITHIUM TOXICITY
![Page 59: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/59.jpg)
![Page 60: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/60.jpg)
SympathoplegicsSympathoplegics
![Page 61: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/61.jpg)
SympathoplegicsSympathoplegics
• Centrally-acting
• Peripherally-acting
• Alpha-1 blockers
• Beta blockers
![Page 62: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/62.jpg)
Centrally-Acting Centrally-Acting SympathoplegicsSympathoplegics
![Page 63: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/63.jpg)
Centrally-Acting Centrally-Acting SympathoplegicsSympathoplegics• MOA: act primarily within the CNS on
alpha-2 receptors to decrease sympathetic outflow to the CVS
• Clonidine• Methyldopa• Guanfacine• Guanabenz
![Page 64: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/64.jpg)
ClonidineClonidine
• MOA: agonist at alpha-2 receptors (leading to vasodilation)
• effective in patients with renal impairment
• SE: transient increase in BP, sedation/depression, rebound hypertension on abrupt withdrawal
![Page 65: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/65.jpg)
MethyldopaMethyldopa
• reduce TPR with little effect on CO and blood flow to vital organs (such as kidneys)
• effective for patients with renal impairment
• used in the management of HTN in pregnancy (pre-eclampsia, eclampsia)
![Page 66: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/66.jpg)
MethyldopaMethyldopa
• SE: sedation, depression, hepatotoxicity (at doses >2g / day), (+) Coomb,s Test*
* Coomb’s Test – indicator of a possible immune-mediated hemolytic anemia
![Page 67: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/67.jpg)
Guanfacine, GuanabenzGuanfacine, Guanabenz
• adjunctive therapy to other anti-HTNsive drugs
• avoided unless necessary to treat severe refractory HTN that is unresponsive to other meds
![Page 68: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/68.jpg)
Peripherally-Acting Peripherally-Acting SympathoplegicsSympathoplegics
![Page 69: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/69.jpg)
Peripherally-Acting Peripherally-Acting SympathoplegicsSympathoplegics
• Trimethaphan
• Reserpine
• Guanethidine
• Guanadrel
![Page 70: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/70.jpg)
TrimethaphanTrimethaphan
• ganglionic receptor blocker
• given via IV infusion
• used in hypertensive emergencies caused by pulmonary edema or aortic aneurism when other agents cannot be used
![Page 71: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/71.jpg)
ReserpineReserpine
• plant alkaloid
• inhibits catecholamine (NE, Epi, Dopamine, Serotonin) storage
• impairs sympathetic function because of decreased release of Norepinephrine (NE)
![Page 72: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/72.jpg)
Guanethidine, GuanadrelGuanethidine, Guanadrel
• inhibit the response of the adrenergic nerve to stimulation or to indirectly-acting sympathetic amines
• blocks the release of stored Norepinephrine
• SE: orthostatic hypotension, impaired male sexual function
![Page 73: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/73.jpg)
Alpha-1 BlockersAlpha-1 Blockers
![Page 74: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/74.jpg)
Alpha-1 BlockersAlpha-1 Blockers
• MOA: inhibit the alpha-1 receptors, resulting to vasodilation of arteries and veins
• Prazosin• Doxazosin• Alfazosin• Terazosin
![Page 75: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/75.jpg)
Alpha-1 BlockersAlpha-1 Blockers
• alternative drugs for the management of HTN esp among patients with BPH
• First-Dose Phenomenon:– orthostatic hypotension– syncope– remedy: take the drug at bedtime, slow
increase in dose
![Page 76: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/76.jpg)
Beta BlockersBeta Blockers
![Page 77: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/77.jpg)
Beta BlockersBeta Blockers
• used for the initial therapy of HTN; effective for patients with rapid resting HR or concomitant IHD
• MOA– Block stimulation of renin secretion– Decrease contractility decrease CO– Decrease sympathetic output centrally– Reduction in HR reduced CO– Combination of all
![Page 78: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/78.jpg)
Beta BlockersBeta Blockers
• SE/Precautions/Contraindications:– can mask hypoglycemia– CI to patients with bronchospastic disease:
COPD, Bronchial Asthma– rebound tachycardia and HTN– easy fatigability– severe bradycardia and heartblock (seen
esp with concomitant use of verapamil and diltiazem)
![Page 79: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/79.jpg)
Beta BlockersBeta Blockers• Selective
B – Betaxolol
B – Bisoprolol
E – Esmolol
A – Acebutolol
A – Atenolol
M – Metoprolol
• Membrane Stabilizing Activity – Anesthetic-like effect– Cannot be given as
ophthalmic drops
P – Propranolol
P – Pindolol
A – Acebutolol
L – Labetalol
M – Metoprolol
![Page 80: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/80.jpg)
Beta BlockersBeta Blockers• Mixed alpha and
beta blocking effect
L – Labetalol
C – Carvedilol
• Intrinsic sympathomimetic activity– partial agonist effect– not usually associated
with rebound hypertension
A – Acebutolol
B – Bisoprolol
C – Carteolol
P – Pindolol
P - Penbutolol
![Page 81: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/81.jpg)
Nematodes (Roundworms)Nematodes (Roundworms)
![Page 82: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/82.jpg)
Nematodes (Roundworms)Nematodes (Roundworms)
![Page 83: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/83.jpg)
VasodilatorsVasodilators
![Page 84: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/84.jpg)
VasodilatorsVasodilators
• second-line agents
• directly relax the peripheral vascular smooth muscles
• not used alone inc in plasma renin activity, CO, HR
![Page 85: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/85.jpg)
VasodilatorsVasodilators
• common SE: reflex tachycardia, peripheral edema
• common CI: as single agents, should be avoided in patients with Ischemic Heart Disease (IHD)
![Page 86: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/86.jpg)
VasodilatorsVasodilators
• Hydralazine
• Diazoxide
• Minoxidil
• Sodium Nitroprusside
![Page 87: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/87.jpg)
HydralazineHydralazine
• used in the management of HTN in pregnancy
• SE: Lupus-like side effect (drug-induced SLE or Systemic Lupus Erythematosus)
![Page 88: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/88.jpg)
DiazoxideDiazoxide
• used in the emergency treatment of hypertensive crisis
![Page 89: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/89.jpg)
MinoxidilMinoxidil
• most effective arteriolar vasodilator
• SE: hypertrichosis, hirsutism
![Page 90: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/90.jpg)
Sodium NitroprussideSodium Nitroprusside
• metabolized in the body into nitric oxide (NO) also called EDRF or Endothelium-Derived Relaxing Factor
• 1st line drug for almost all types of HTNsive emergencies
![Page 91: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/91.jpg)
Sodium NitroprussideSodium Nitroprusside
• Caution: use freshly prepared solutions or admixtures
• protect from light
• SE: thiocyanate or cyanide toxicity, acute psychosis, severe hypotension, coma, death
![Page 92: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/92.jpg)
Calcium Channel BlockersCalcium Channel Blockers
![Page 93: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/93.jpg)
Calcium Channel Blockers Calcium Channel Blockers (CCBs)(CCBs)• alternative for the mgt of HTN
• MOA– Inhibit influx of Ca through the slow
channels in vascular smooth muscle and cause relaxation
![Page 94: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/94.jpg)
• Dihydropyridine (DHP)– block Ca channels in the blood vessels– Nifedipine, Nicardipine, Felodipine, Amlodipine
• Non-dihydropyridine (Non-DHP)– block Ca channels both in the heart and blood
vessels– Verapamil – heart > blood vessels– Diltiazem – heart = blood vessels
ClassificationClassification
![Page 95: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/95.jpg)
Calcium Channel Blockers Calcium Channel Blockers (CCBs)(CCBs)• SE:
– peripheral edema
– reflex tachycardia (DHP)
– bradycardia (Non-DHP)
– heart block (Non-DHP + Beta Blocker)
![Page 96: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/96.jpg)
ACE InhibitorsACE Inhibitors
![Page 97: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/97.jpg)
Angiotensin Converting Enzyme Angiotensin Converting Enzyme InhibitorsInhibitors• MOA: inhibit ACE, thereby preventing the
conversion of angiotensin I into the active form angiotensin II
• Short-acting– Captopril
• Long-acting– Enalapril– Lisinopril– Perindopril
Generally, long acting ACE Inhibitors are prodrugs:
Enalapril Enalaprilat
(prodrug) (active)
![Page 98: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/98.jpg)
• SE:– idiosyncratic dry cough
ACE
Bradykinin inactive fragments
(causes cough)
– angioedema– hyperkalemia
Angiotensin Converting Enzyme Angiotensin Converting Enzyme InhibitorsInhibitors
![Page 99: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/99.jpg)
Angiotensin II Receptor Angiotensin II Receptor Blockers Blockers
![Page 100: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/100.jpg)
Angiotensin II Receptor Angiotensin II Receptor Blockers (ARBs)Blockers (ARBs)
• direct inhibitors of angiotensin II receptors
• Losartan, Valdesartan, Candesartan
• clinical use: same as ACE Inhibitors
• Advantage over ACE inhibitors: less associated with dry cough
![Page 101: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/101.jpg)
1. A friend has very severe hypertension and asks 1. A friend has very severe hypertension and asks about a drugabout a drug her doctor wishes to prescribe. Her her doctor wishes to prescribe. Her physician has explained that this drug is physician has explained that this drug is associated with tachycardia and fluid retention (w/c associated with tachycardia and fluid retention (w/c may be marked) and increased hair growth. Which may be marked) and increased hair growth. Which of the following is most likely to produce the effects of the following is most likely to produce the effects that your friend has described?that your friend has described?
A. Captopril
B. Guanethidine
C. Minoxidil
D. Prazosin
E. Propanolol
![Page 102: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/102.jpg)
2. A patient is admitted to the emergency 2. A patient is admitted to the emergency department with severe bradycardia following a department with severe bradycardia following a drug overdose. His family reports that he has been drug overdose. His family reports that he has been depressed about his hypertension. Each of the depressed about his hypertension. Each of the following can slow the heart rate EXCEPTfollowing can slow the heart rate EXCEPT
A. Clonidine
B. Guanethidine
C. Hydralazine
D. Propanolol
E. Reserpine
![Page 103: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/103.jpg)
2. A patient is admitted to the emergency 2. A patient is admitted to the emergency department with severe bradycardia following a department with severe bradycardia following a drug overdose. His family reports that he has been drug overdose. His family reports that he has been depressed about his hypertension. Each of the depressed about his hypertension. Each of the following can slow the heart rate EXCEPTfollowing can slow the heart rate EXCEPT
A. Clonidine
B. Guanethidine
C. Hydralazine
D. Propanolol
E. Reserpine
![Page 104: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/104.jpg)
2. A patient is admitted to the emergency 2. A patient is admitted to the emergency department with severe bradycardia following a department with severe bradycardia following a drug overdose. His family reports that he has been drug overdose. His family reports that he has been depressed about his hypertension. Each of the depressed about his hypertension. Each of the following can slow the heart rate EXCEPTfollowing can slow the heart rate EXCEPT
A. Clonidine
B. Guanethidine
C. Hydralazine
D. Propanolol
E. Reserpine
![Page 105: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/105.jpg)
3. Which one of the following is characteristic of 3. Which one of the following is characteristic of enalapril treatment in patients with essential enalapril treatment in patients with essential hypertension?hypertension?
A. Competitively blocks angiotensin II at its receptor
B. Decreases angiotensin II concentration in the blood
C. Decreases renin concentration in the blood
D. Increases sodium and decreases potassium in the blood
E. Decreases sodium and increases potassium in the urine
![Page 106: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/106.jpg)
4. A pregnant patient is admitted to the 4. A pregnant patient is admitted to the hematology service with moderately severe hematology service with moderately severe hemolytic anemia. After a thorough workup, the hemolytic anemia. After a thorough workup, the only positive finding is a history of treatment with only positive finding is a history of treatment with an antihypertensive drug since 2 months after an antihypertensive drug since 2 months after beginning the pregnancy. The most likely cause of beginning the pregnancy. The most likely cause of the patient’s blood disorder isthe patient’s blood disorder is
A. Atenolol
B. Captopril
C. Hydralazine
D. Methyldopa
E. Minoxidil
![Page 107: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/107.jpg)
5. Postural hypotension is a common 5. Postural hypotension is a common adverse effect of which one of the adverse effect of which one of the following types of drugs?following types of drugs?
A. ACE inhibitors
B. Alpha receptor blockers
C. Arteriolar dilators
D. Beta-selective receptor blockers
E. Nonselective B-blockers
![Page 108: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/108.jpg)
5. Postural hypotension is a common 5. Postural hypotension is a common adverse effect of which one of the adverse effect of which one of the following types of drugs?following types of drugs?
A. ACE inhibitors
B. Alpha receptor blockers
C. Arteriolar dilators
D. Beta-selective receptor blockers
E. Nonselective B-blockers
![Page 109: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/109.jpg)
5. Postural hypotension is a common 5. Postural hypotension is a common adverse effect of which one of the adverse effect of which one of the following types of drugs?following types of drugs?
A. ACE inhibitors
B. Alpha receptor blockers
C. Arteriolar dilators
D. Beta-selective receptor blockers
E. Nonselective B-blockers
![Page 110: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/110.jpg)
Congestive Heart FailureCongestive Heart Failure
![Page 111: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/111.jpg)
Heart FailureHeart Failure
• is the failure of the heart as a pump
• inability of the heart to pump sufficient amount of blood to the body
![Page 112: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/112.jpg)
Congestive Heart FailureCongestive Heart Failure
• pumping ability of the heart becomes impaired
• accompanied by congestion of body tissues
• etiology– acute MI, HPN, cardiomyopathies
– excessive work demands on the heart
![Page 113: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/113.jpg)
Forms of CHFForms of CHF• High-output
– uncommon– caused by excessive
need for cardiac output
– high metabolic demands
• Low-output– caused by disorders
that impair the pumping ability of the heart (IHD)
– normal metabolic demands, heart unable to meet them
![Page 114: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/114.jpg)
Forms of CHFForms of CHF• Right sided
– fatigue– jugular vein distension– liver engorgement– anorexia, GI distress– cyanosis– elevation in peripheral
venous pressure– peripheral edema
• Left-sided– exertional dyspnea– paroxysmal nocturnal
dyspnea– cough– blood-tinged sputum– cyanosis– pulmonary edema
![Page 115: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/115.jpg)
Treatment GoalsTreatment Goals• To remove or mitigate the underlying cause • To relieve the symptoms and improve pump
function by:– Reducing metabolic demands (rest, relaxation,
pharm’l controls)– Reduce fluid volume excess (food intake, meds)– Administer digitalis and other inotropic agents– Promote px compliance and self-regulation
through education– Select appropriate px for cardiac transplants
![Page 116: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/116.jpg)
Compensatory MechanismCompensatory Mechanism
• Myocardial Hypertrophy– long-term compensatory mechanism
– increase in the number of contractile elements in myocardial cells as a means of increasing their myocardial performance
– ventricular remodeling
![Page 117: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/117.jpg)
Compensatory MechanismCompensatory Mechanism
• Frank-Starling Mechanism– is the intrinsic ability of the heart to adapt to
changing volumes of inflowing blood– the greater the heart muscle is stretched
during filling, the greater the force of contraction and the greater the quantity of blood pumped into the aorta
– within physiologic limits, the heart pumps all the blood that comes to it without allowing excessive damming of blood in the veins
![Page 118: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/118.jpg)
Drugs for CHFDrugs for CHF
![Page 119: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/119.jpg)
Drugs for CHFDrugs for CHF
• Inotropic Agents– Cardiac glycosides– Beta Agonists– Phosphodiesterase Inhibitors
• Unloaders– ACE Inhibitors & ARBs– Beta Blockers– Diuretics– Vasodilators
![Page 120: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/120.jpg)
TREATING CONGESTIVE HEART FAILURE
U
N
L
O
A
D
UPRIGHT POSITION
NITRATES (LOW DOSE)
LASIX
OXYGEN
AMINOPHYLLINE
DIGOXIN
F
A
S
T
FLUIDS (DECREASE)
AFTERLOAD (DECREASE)
SODIUM RESTRICTION
TEST (Dig Level, ABGs, Potassium Level)
![Page 121: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/121.jpg)
Cardiac GlycosidesCardiac Glycosides
• from Digitalis species
• Digoxin, Digitoxin
• MOA: inhibit the Na-K-ATPase pump leading to an increase in intracellular calcium
![Page 122: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/122.jpg)
Cardiac GlycosidesCardiac Glycosides
• Digoxin – ~75% Bioavailable– half-life: 36-40
hours– 20-40% protein
bound– excreted in the
urine
• Digitoxin– >90% Bioavailable– half-life: 168 hours– >90% protein bound– excreted in the bile
![Page 123: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/123.jpg)
Cardiac GlycosidesCardiac Glycosides
- have low therapeutic indices
- toxicity can be enhanced by:- hypokalemia
- hypomagnesemia
- hypercalcemia
![Page 124: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/124.jpg)
ToxicityToxicity
• Cardiac Manifestations– arrhythmias (ventricular tachycardia)– cardiac death
• Extra-cardiac Manifestations– GI disturbances (nausea & vomiting)– visual disturbances (blurred vision, alteration
of color perception, haloes on dark objects)
![Page 125: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/125.jpg)
Management of ToxicityManagement of Toxicity
• give potassium supplement
• give digitalis antibodies (FAB fragments)
• for arrhythmias, give lidocaine or amiodarone
![Page 126: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/126.jpg)
![Page 127: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/127.jpg)
Nematodes (Roundworms)Nematodes (Roundworms)
![Page 128: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/128.jpg)
Beta-1 AgonistsBeta-1 Agonists
• Dopamine
• Dobutamine
• MOA: increase intracellular cAMP, which results in the activation of protein kinase, that leads to an increase in intracellular calcium
![Page 129: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/129.jpg)
DobutamineDobutamine
• given as an IV infusion
• primarily used in the management of acute heart failure in the hospital setting
![Page 130: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/130.jpg)
Phosphodiesterase InhibitorsPhosphodiesterase Inhibitors
• MOA: inhibits the enzyme phosphodiesterase which hydrolyses cAMP , thereby prolonging the action of protein kinase
• Amrinone
• Milrinone
![Page 131: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/131.jpg)
UnloadersUnloaders• ACE Inhibitors & ARBs
– preload and afterload unloaders– vasodilating effect– Captopril, Enalapril
• Beta Blockers– vasodilating effect– Metoprolol, Misoprolol, Carvedilol
• Diuretics– preload unloaders– Spironolactone
• Vasodilators– Hydralazine, Nitroprusside
![Page 132: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/132.jpg)
1. Drugs that have been found to be useful in one 1. Drugs that have been found to be useful in one or more types of heart failure include all of the or more types of heart failure include all of the following EXCEPTfollowing EXCEPT
A. Na+/K+ ATPase inhibitors
B. Alpha-adrenoceptor agonists
C. Beta-adrenoceptor agonists
D. ACE inhibitors
![Page 133: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/133.jpg)
2. The mechanism of action of digitalis is 2. The mechanism of action of digitalis is associated withassociated with
A. A decrease in calcium uptake by the sarcoplasmic reticulum
B. An increase in ATP synthesis
C. A modification of the actin molecule
D. An increase in systolic intracellular calcium levels
E. A block of cardiac B adrenoceptors
![Page 134: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/134.jpg)
4. A 65-year old woman has been admitted to the 4. A 65-year old woman has been admitted to the coronary care unit with a left ventricular myocardial coronary care unit with a left ventricular myocardial infarction. If this patient develops acute severe infarction. If this patient develops acute severe heart failure with mark pulmonary edema, which heart failure with mark pulmonary edema, which one of the following would be most useful?one of the following would be most useful?
A. Digoxin
B. Furosemide
C. Minoxidil
D. Propanolol
E. Spironolactone
![Page 135: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/135.jpg)
6. Drugs associated with clinically useful or 6. Drugs associated with clinically useful or physiologically important positive inotropic effects physiologically important positive inotropic effects include all of the following EXCEPTinclude all of the following EXCEPT
A. Amrinone
B. Captopril
C. Digoxin
D. Dobutamine
E. Norepinphrine
![Page 136: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/136.jpg)
7. Successful therapy of heart failure with digoxin 7. Successful therapy of heart failure with digoxin will result in which one of the following?will result in which one of the following?
A. Decreased heart rate
B. Increased afterload
C. Increased aldosterone
D. Increased renin secretion
E. Increased sympathetic outflow to the heart
![Page 137: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/137.jpg)
8. Which of the following has been shown to 8. Which of the following has been shown to prolong life in patients with chronic congestive prolong life in patients with chronic congestive failure but has a negative inotropic effect on failure but has a negative inotropic effect on cardiac contractility?cardiac contractility?
A. Carvedilol
B. Digoxin
C. Dobutamine
D. Enalapril
E. Furosemide
![Page 138: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/138.jpg)
10. Which of the following is the drug of choice in 10. Which of the following is the drug of choice in treating suicidal overdose of digitoxin?treating suicidal overdose of digitoxin?
A. Digoxin antibodies
B. Lidocaine
C. Magnesium
D. Phenytoin
E. Potassium
![Page 139: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/139.jpg)
Coronary Artery Diseases Coronary Artery Diseases (CAD)(CAD)
ororIschemic Heart Diseases Ischemic Heart Diseases
(IHD)(IHD)
![Page 140: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/140.jpg)
Coronary Artery DiseasesCoronary Artery Diseases
![Page 141: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/141.jpg)
Coronary Artery DiseasesCoronary Artery Diseases• occur when the
coronary arteries become so narrowed by atherosclerosis that they are unable to deliver sufficient blood to the heart muscle– Localized areas of
thickened tunica intima associated with accumulation of smooth muscle cells and lipids, principally cholesterol
![Page 142: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/142.jpg)
Coronary Artery DiseasesCoronary Artery Diseases• Angina Pectoris
– episodic, reversible oxygen insufficiency– severe chest pains generally radiating to the left shoulder and
down the inner side of the arm– usually precipitated by physical exertion or emotional stress
• Myocardial Ischemia– deprivation of oxygen to a portion of the myocardium (reversible)
• Myocardial Infarction– severe, prolonged deprivation of oxygen to a portion of the
myocardium that leads to myocardial tissue necrosis (reversible)
![Page 143: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/143.jpg)
Risks FactorsRisks Factors
• Smoking• Hypertension• Diabetes Mellitus• Males >45 yo; Females >55 yo• Dyslipidemia• Obesity• Family history of CAD• Others:
– sedentary lifestyle, hx of chronic inflammation
![Page 144: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/144.jpg)
EtiologyEtiology• Decreased blood flow
– Atherosclerosis – most common cause– Coronary artery spasm – sustained contraction of 1 or
more coronary arteries Prinzmetal’s angina or MI– Traumatic injury – that interferes with blood flow in the
heart– Embolic events – can abruptly restrict oxygen supply
• Increased oxygen demand– Exertion and emotional stress sympathetic
stimulation increase HR• Reduced blood oxygenation
– Reduced O2-carrying capacity (anemia)
![Page 145: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/145.jpg)
Angina PectorisAngina Pectoris
• chest pain
• a symptom of myocardial ischemia in the absence of an infaction
![Page 146: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/146.jpg)
Angina PectorisAngina Pectoris
• Types:– Stable Angina
• aka: Classical Angina• develops on exertion and lasts for < 5 min• relieved with rest or drugs• mechanism: imbalance oxygen supply
– Unstable Angina• can be experienced at rest, or with increasing severity for
the last 1-2 months or a new chest pain for < 1 month• mechanism: thrombosis
![Page 147: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/147.jpg)
Angina PectorisAngina Pectoris
• Types:– Angina Decubitus
• nocturnal angina• occurs in recumbent position
– Prinzmetal Angina• aka: Variant Angina• precipitated by coronary artery spasm
![Page 148: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/148.jpg)
![Page 149: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/149.jpg)
Drugs for Angina PectorisDrugs for Angina Pectoris
• Nitrates
• Beta Blockers
• Calcium Channel Blockers
![Page 150: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/150.jpg)
NitratesNitrates
• MOA: metabolized into NO in the body, leading to peripheral vasodilation
• examples– amyl nitrite– nitroglycerin– isosorbide dinitrate (ISDN)– isosorbide mononitrate (ISMN)
• SE:– throbbing headache, tolerance
![Page 151: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/151.jpg)
Beta BlockersBeta Blockers
• drug of choice for stable angina
• MOA: decreases HR & contractility reduce oxygen demand (rest and during exertion) reduce arterial BP
![Page 152: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/152.jpg)
CCBsCCBs• MOA
– inhibits calcium influx into vascular smooth muscle & heart muscles increased blood flow enhance oxygen supply prevent and reverse coronary spasm
– dilates peripheral arterioles & reduce contractility reduce total peripheral vascular resistance reduced oxygen demand
• Indications– Stable angina not controlled by nitrates & beta
blockers; px who could not take beta blockers– Prinzmetal’s angina (with or without nitrates)– DOC of angina at rest
![Page 153: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/153.jpg)
Other AgentsOther Agents
• Morphine– Unstable angina with no CI; IV doses given
after 3 sublingual nitroglycerin tabs have failed to relieve pain
• Aspirin– Indefinite in px with stable or unstable angina
• Heparin, Enoxaparin, Dalteparin– Together with aspirin hospitalized px with
unstable angina until resolved
![Page 154: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/154.jpg)
Myocardial InfarctionMyocardial Infarction
![Page 155: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/155.jpg)
Myocardial Infarction (MI)Myocardial Infarction (MI)
– Results from prolonged myocardial ischemia, precipitated in most cases by an occlusive coronary thrombus at the site of a pre-existing atherosclerotic plaque
Cellular ischemia
Tissue injury
Tissue necrosis
Note:Damage on myocardial tissue is not reversible myocardial tissue dies
![Page 156: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/156.jpg)
Myocardial Infarction (MI)Myocardial Infarction (MI)
![Page 157: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/157.jpg)
Myocardial Infarction (MI)Myocardial Infarction (MI)
• persistent, severe chest pain or pressure “crushing”, “squeezing” or heavy “an elephant sitting on the chest”
![Page 158: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/158.jpg)
Signs and Symptoms of MISigns and Symptoms of MI
• Compared to angina – Pain persists longer– Not relieved by rest or nitroglycerin– Sense of impending doom, sweating, nausea,
vomiting, difficulty in breathing; some px fainting and sudden death
– Extreme anxiety, restlessness, ashen pallor
• Some px:– Mild or indigestion-like pain, manifest in worsening
CHF, loss of consciousness, acute confusion, dyspnea, sudden drop in BP, lethal arrhythmia
![Page 159: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/159.jpg)
Drugs for MIDrugs for MI
![Page 160: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/160.jpg)
IMMEDIATE TREATMENT FOR
MYOCARDIAL INFARCTION
M
O
N
A
MORPHINE
OXYGEN
NITROGLYCERINE
ASA
![Page 161: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/161.jpg)
Drugs for MIDrugs for MI
• Nitrates
• Oxygen
• Morphine
• Thrombolytic Agents
![Page 162: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/162.jpg)
NitratesNitrates• MOA
– Decrease oxygen demand and facilitate coronary blood flow
– converted to nitric oxide intracellularly which activates guanylate cyclase increase cGMP
dephosphorylation of myosin light chain relaxation of vascular smooth muscle vasodilation
• Important SE– HEADACHE – most common side effect– Tolerance (“Nitrate-free interval”)– Postural hypotension, facial flushing, reflex
tachycardia
![Page 163: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/163.jpg)
![Page 164: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/164.jpg)
OxygenOxygen
• for patients who have chest pain and who may be ischemic
• improve oxygenation of myocardium
![Page 165: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/165.jpg)
MorphineMorphine
• MOA– causes venous pooling and reduces preload,
cardiac workload, and oxygen consumption– IV until pain is relieved
• Indication– DOC for MI pain and anxiety
• Precautions– can produce orthostatic hypotension and fainting– monitor for hypotension & signs of resp depression– GI SE: nausea and vomiting; constipation
![Page 166: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/166.jpg)
Thrombolytic AgentsThrombolytic Agents
• MOA:– Lysis of thrombus clot
• The following are given IV within 12 h to restore normal blood flow in an acute MI:– Recombinant t-PA (recombinant tissue-type
plasminogen activator alteplase)– Streptokinase– Anisoylated plasminogen streptokinase activator
complex (APSAC)– Reteplase– Tenecteplase
![Page 167: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/167.jpg)
Post thrombolysis adjunctive Post thrombolysis adjunctive therapytherapy• Aspirin
– prevents platelet aggregation; shown to reduce post-infarct mortality
– also: dipyridamole, ticlopidine, clopidogrel
• Heparin– prevent re-occlusion once a coronary artery has
been opened– not used with streptokinase increased risk of
hemorrhage
• Warfarin– reduce mortality, prevent recurrent MI
![Page 168: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/168.jpg)
Post thrombolysis adjunctive Post thrombolysis adjunctive therapytherapy• Beta Blockers
– if administered early reduce ischemia, reduce potential zone of infarction, decrease oxygen demands, preserve left ventricular function, decrease cardiac workload
• ACE Inhibitors– improve exercise capacity and reduce mortality
in px with CHF; aid in the prevention of progressive ventricular remodelling
• “Statins”– reduced mortality due to MI when used by px to
aggressively lower cholesterol
![Page 169: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/169.jpg)
Post thrombolysis adjunctive Post thrombolysis adjunctive therapytherapy
• Lidocaine– used for px who develop ventricular
arrhythmia
• Calcium Channel Blockers– decrease incidence of reinfarction in px
with non-Q-wave infarcts; not for acute mgt.
![Page 170: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/170.jpg)
Items 1-3. Mr. Green, 60 years old, has Items 1-3. Mr. Green, 60 years old, has severe chest pain when he attempts to carry severe chest pain when he attempts to carry parcels upstairs to his apartment. The pain parcels upstairs to his apartment. The pain rapidly disappears when he rest. A decision rapidly disappears when he rest. A decision is made to treat him with nitroglycerin.is made to treat him with nitroglycerin.
![Page 171: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/171.jpg)
2. In advising Mr. Green about the adverse effects 2. In advising Mr. Green about the adverse effects he may notice, you point out that nitroglycerin in he may notice, you point out that nitroglycerin in moderate doses often produces certain symptoms. moderate doses often produces certain symptoms. These toxicities result from all of the following These toxicities result from all of the following EXCEPTEXCEPT
A. Meningeal vasodilation
B. Reflex tachycardia
C. Hypotension
D. Methemoglobinemia
![Page 172: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/172.jpg)
3. 2 years later, Mr. Green returns complaining 3. 2 years later, Mr. Green returns complaining that his nitroglycerin works well when he takes it that his nitroglycerin works well when he takes it for an acute attack but that he is having frequent for an acute attack but that he is having frequent attacks now and would like something to prevent attacks now and would like something to prevent them. Useful drugs for the prophylaxis of angina of them. Useful drugs for the prophylaxis of angina of effort include which one of the following?effort include which one of the following?
A. Amyl nitrite
B. Diltiazem
C. Sublingual isosorbide dinitrate
D. Sublingual nitroglycerin
![Page 173: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/173.jpg)
4. The antianginal effect of propanolol may be 4. The antianginal effect of propanolol may be attributed to which one of the following?attributed to which one of the following?
A. Block of exercise-induced tachycardia
B. Decreased end-diastolic ventricular volume
C. Dilation of constricted coronary vessels
D. Increased cardiac force
E. Decreases heart rate
![Page 174: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/174.jpg)
5. The major common determinant of myocardial 5. The major common determinant of myocardial oxygen consumption isoxygen consumption is
A. Blood volume
B. Cardiac output
C. Diastolic blood pressure
D. Heart rate
E. Myocardial fiber tension
![Page 175: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/175.jpg)
6. You are considering therapeutic options for a 6. You are considering therapeutic options for a new patient who presents with hypertension and new patient who presents with hypertension and angina. In considering adverse effects, you note angina. In considering adverse effects, you note that an adverse effect which nitroglycerin, that an adverse effect which nitroglycerin, prazosin, and ganglion blockers have in common prazosin, and ganglion blockers have in common isis
A. Bradycardia
B. Impaired sexual function
C. Lupus erythematosus syndrome
D. Orthostatic hypotension
E. Throbbing headache
![Page 176: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/176.jpg)
7. A patient is admitted to the emergency 7. A patient is admitted to the emergency department following a drug overdose. He is noted department following a drug overdose. He is noted to have severe tachycardia. He has been receiving to have severe tachycardia. He has been receiving therapy for hypertension and angina. A drug that therapy for hypertension and angina. A drug that often causes tachycardia isoften causes tachycardia is
A. Diltiazem
B. Guanethidine
C. Isosorbide dinitrate
D. Propanolol
E. Verapamil
![Page 177: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/177.jpg)
ArrhythmiasArrhythmias
![Page 178: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/178.jpg)
ArrhythmiasArrhythmias
• deviations from normal heartbeat pattern– abnormalities in impulse formation
– conduction disturbances
![Page 179: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/179.jpg)
ArrhythmiasArrhythmias
• The heart is endowed with a specialized electrogenic system for:– Generating rhythmical impulses to
cause rhythmical contraction of the heart muscle
– Conducting these impulses rapidly throughout the heart
![Page 180: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/180.jpg)
Cardiac Conduction SystemCardiac Conduction System
• Sinoatrial node – Pacemaker of the heart– 60 – 100 beats/min– Location: posterior wall of the right atrium near the
entrance of the superior vena cava
• Atrioventricular node– Location: posterior septal wall of the right atrium
immediately behind the tricuspid valve– Connects the atrial and ventricular conduction
systems
![Page 181: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/181.jpg)
Cardiac Conduction SystemCardiac Conduction System• Bundle of His (AV bundle)
– Delayed transmission• Delays in transmission provide mechanical
advantage atria complete ejection of blood before initiating ventricular contraction
• Purkinje system– Supplies the ventricles– Has large fibers that allow for rapid conduction and
almost simultaneous excitation of the entire left and right ventricles
– Rapid rate of ejection is necessary for the swift and efficient ejection of blood from the heart
![Page 182: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/182.jpg)
Cardiac Conduction SystemCardiac Conduction System
![Page 183: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/183.jpg)
Myocardial Action PotentialMyocardial Action Potential
• electric current generated by nerve and muscle cells
• involve movement or flow of electrically charged ions at the level of the cell membrane
![Page 184: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/184.jpg)
Myocardial Action PotentialMyocardial Action Potential
![Page 185: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/185.jpg)
Resting Membrane PotentialResting Membrane Potential• membrane is
relatively permeable to K+
• charges of opposite polarity become aligned along the membrane
(+) outside
(-) inside
![Page 186: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/186.jpg)
DepolarizationDepolarization• cell membrane
suddenly becomes selectively permeable to current-carrying ions such as Na+
• Na+ enters cell sharp rise of intracellular potential to positivity while K+ migrate outside
![Page 187: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/187.jpg)
RepolarizationRepolarization• re-establishment of the
resting potential• slower process;
increased permeability to K+ K+ ions move outward removes (+) charges inside the cell– The Na-K pump helps
to preserve the intracellular negativity by moving 3 Na+ ions out of the cell in exchange for 2 K+ ions.
![Page 188: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/188.jpg)
Myocardial Action PotentialMyocardial Action Potential
• Five Phases:Phase 0: Rapid Depolarization
Phase 1: Early Rapid Repolarization
Phase 2: Plateau Phase of Repolarization
Phase 3: Final Rapid Repolarization
Phase 4: Slow Depolarization
![Page 189: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/189.jpg)
Myocardial Action PotentialMyocardial Action Potential
![Page 190: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/190.jpg)
Myocardial Action PotentialMyocardial Action Potential
![Page 191: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/191.jpg)
Electrocardiography (ECG)Electrocardiography (ECG)
• A recording of the electrical activity of the heart during depolarization-repolarization– P wave
• SA node and atrial depolarization
– QRS complex• Ventricular depolarization
– T wave• Ventricular repolarization
![Page 192: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/192.jpg)
Electrocardiography (ECG)Electrocardiography (ECG)
– Isoelectric line between P wave & Q wave• Depolarization of the AV node, bundle
branches, Purkinje system
– ST segment• Absolute refractory period; part of ventricular
repolarization
– Atrial repolarization occurs during ventricular depolarization and is hidden in the QRS complex.
![Page 193: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/193.jpg)
Cardiac arrhythmia may Cardiac arrhythmia may cause the heart tocause the heart to• To beat too slowly
• To beat too rapidly
• To respond to impulses originating from sites other than the SA node
• To respond to impulses travelling along extra pathways
![Page 194: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/194.jpg)
CAUSES OF ARRHYTHMIACAUSES OF ARRHYTHMIA
• Abnormal automaticity
• Effect of drug
• Abnormalities in impulse conduction
![Page 195: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/195.jpg)
![Page 196: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/196.jpg)
![Page 197: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/197.jpg)
Electrocardiography (ECG)Electrocardiography (ECG)
![Page 198: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/198.jpg)
Action Potential & ECGAction Potential & ECG
![Page 199: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/199.jpg)
Classification of ArrhythmiasClassification of Arrhythmias
• By origin– Supraventricular arrhythmia
• Stem from enhanced automaticity of the SA node or from re-entry conduction
– Ventricular arrhythmia• Occur when an ectopic pacemaker triggers
a ventricular contraction before the SA node fires
![Page 200: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/200.jpg)
Normal ECG PatternNormal ECG Pattern
![Page 201: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/201.jpg)
ECG Patterns of ArrhythmiasECG Patterns of Arrhythmias
![Page 202: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/202.jpg)
Anti-arrhythmic AgentsAnti-arrhythmic Agents
![Page 203: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/203.jpg)
AntiarrhythmicsAntiarrhythmicsSodium Channel Blockers
Class IA
Class IB
Class IC
•Quinidine•Procainamide•Disopyramide
•Lidocaine•Tocainide•Mexiletine•Phenytoin
•Flecainide•Propafenone•Moricizine
Beta Adrenergic Blockers Class II•Propranolol•Esmolol•Acebutolol
Potassium Channel Blockers Class III•Amiodarone•Sotalol•Bretylium
Calcium Channel Blockers Class IV•Verapamil•Diltiazem
![Page 204: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/204.jpg)
![Page 205: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/205.jpg)
CLASS 1ACLASS 1A
• Slows phase 0 depolarization
• Prolong action potential
• Slow conduction
![Page 206: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/206.jpg)
CLASS 1BCLASS 1B
• Shortens phase 3 repolarization
• Decrease duration of action potential
![Page 207: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/207.jpg)
CLASS 1CCLASS 1C
• Markedly slow phase 0 depolarization
![Page 208: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/208.jpg)
CLASS IICLASS II
• Suppresses phase 4 depolarization
![Page 209: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/209.jpg)
CLASS IIICLASS III
• Prolongs phase 3 repolarization
![Page 210: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/210.jpg)
CLASS IVCLASS IV
• Slows phase 4 spontaneous depolarization
• Shorten action potential
![Page 211: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/211.jpg)
Miscellaneous AgentsMiscellaneous Agents
• Adenosine
• MgSO4
![Page 212: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/212.jpg)
TYPE OF ARRHYTHMIA TYPE OF ARRHYTHMIA AND DRUGSAND DRUGS• Atrial flutter
• Class 1 – quinidine
• Class II - propranolol
• Class IV – verapamil
• Others - digoxin
![Page 213: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/213.jpg)
• Atrial fibrillation
• 1- quinidine
• 2- propranolol
• 3- amniodarone
• 4 – anticoagulant
![Page 214: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/214.jpg)
• AV –NODAL REENTRY
• PROPRANOLOL
• VERAPAMIL
• DIGOXIN
![Page 215: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/215.jpg)
• ACUTE SUPRAVENTRICULAR TACHYCARDIA
• Verapamil
• adenosine
![Page 216: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/216.jpg)
• ACUTE VENTRICULAR TACHYCARDIA
• Lidocaine
• Sotalol
• Amniodarone
![Page 217: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/217.jpg)
• VENTRICULAR FIBBRILLATION
• Lidocaine
• Bretylium
• Amnidarone
• epinephrine
![Page 218: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/218.jpg)
ProcainamideProcainamide
• can cause SLE (Systemic Lupus Erythematosus)
![Page 219: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/219.jpg)
QuinidineQuinidine
• drug interaction with digoxin
• can increase serum levels of digoxin by at least 2x
![Page 220: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/220.jpg)
LidocaineLidocaine
• anesthetic
• DOC for digitalis-induced arrhythmias
![Page 221: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/221.jpg)
PropafenonePropafenone
• for acute atrial fibrillation
![Page 222: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/222.jpg)
AmiodaroneAmiodarone
• iodine-containing molecule
• first-line treatment for almost all types of Ventricular Tachycardia and Atrial Fibrillation
![Page 223: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/223.jpg)
VerapamilVerapamil
• alternative for acute SVT (Supraventricular Tachycardia)
![Page 224: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/224.jpg)
AdenosineAdenosine
• first-line drug for acute SVT
![Page 225: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/225.jpg)
Drugs for Coagulation Drugs for Coagulation DisordersDisorders
![Page 226: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/226.jpg)
Clotting MechanismClotting Mechanism• inciting event: epithelial vascular injury• followed by:
– migration of platelets to the site of injury– platelet aggregation
• aka: primary hemostasis• white thrombus• platelet plug• unstable clot
– deposition of fibrin over the plug– attachment of other blood cells
• aka: secondary hemostasis• red thrombus• stable clot
![Page 227: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/227.jpg)
Clotting MechanismClotting Mechanism
• thrombus– clot that adheres to a blood vessel wall
• embolus– detached thrombus
![Page 228: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/228.jpg)
Clotting MechanismClotting Mechanism
• the coagulation process that generates thrombin that is essential in the formation of fibrin used in clot formation involves coagulation cascade
![Page 229: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/229.jpg)
Coagulation CascadeCoagulation Cascade
![Page 230: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/230.jpg)
Drugs for Coagulation Drugs for Coagulation DisordersDisorders
Anticoagulants
Anti-Platelet Drugs
Fibrinolytic Agents
Pro-coagulant Drugs
![Page 231: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/231.jpg)
AnticoagulantsAnticoagulants
![Page 232: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/232.jpg)
AnticoagulantsAnticoagulants
• Site of action– synthesis of or directly against clotting factors (II,
IIa)
• Types:– Parenteral
• Hirudin, Heparin
– Oral• Dicumarol, Warfarin
![Page 233: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/233.jpg)
Parenteral AnticoagulantsParenteral Anticoagulants
![Page 234: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/234.jpg)
HirudinHirudin
• obtained from medicinal leeches (Hirudo medicinalis)
• used in the management of HIT (Heparin-Induced Thrombocytopenia)
• Lepirudin – produced by recombinant DNA technology
![Page 235: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/235.jpg)
HeparinHeparin• heterogeneous mixture of sulfated
mucopolysaccharides– Regular or Unfractionated heparin
• activates antithrombin III which in turn inactivates thrombin (IIa); Ixa, Xa, Xia
• SQ/IV
– Low MW Heparin• Inactivates IIa and Xa• Enoxaparin,fraxiparin,dalteparin• SQ
![Page 236: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/236.jpg)
HeparinHeparin• Clinical use
– initiation of anticoagulant therapy– mgt of MI or unstable angina– tx & prevention of pulmonary embolism & DVT– anticoagulation in pregnancy (APAS)
• SE:– hemorrhage (monitor aPTT – activated partial
thromboplastin time) 2-2.5x or delay of 50 – 80 secs except SQ
– Thrombocytopenia– osteoporosis– antidote: protamine sulfate
![Page 237: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/237.jpg)
CONTRAINDICATIONSCONTRAINDICATIONS
• Hypersensitivity
• Active bleeding
• Thrombocytopenia
• Severe HPN
• Active TB
![Page 238: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/238.jpg)
Oral AnticoagulantsOral Anticoagulants
![Page 239: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/239.jpg)
• DICUMAROL
• aka: bis-hydroxycoumarin
• high incidence of GI side-effects
• PHENPROCOUMON
• INDANEDIONES ex: anisindione,phenindione
• WARFARIN
![Page 240: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/240.jpg)
• MOA: blocks carboxylation of X, IX,VII,II
• ONSET: 8 – 12 hrs maximum after 1 to 3days
![Page 241: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/241.jpg)
• delay in the anticoagulant effect• Clinical use
– Chronic anticoagulation (DVT prophylaxis, cardiac thrombus, prosthetic heart valves)
• SE:– Hemorrhage
• Monitor PT (Prothrombin Time) and INR (International Normalized Ratio)
• Goal for INR = 2-3• <2 insufficient dose• >3 x’sive dose• With prosthetic heart valves INR goal = 3-4• Antidote: Vit K, FFP
![Page 242: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/242.jpg)
SE:SE:
• Hemorrhagic dse of the newborn
• Teratogenic: abnormal bone formation
• Cutaneous necrosis
• Purple toe syndrome
• Alopecia, urticaria,dermatitis
![Page 243: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/243.jpg)
Anti-Platelet DrugsAnti-Platelet Drugs
![Page 244: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/244.jpg)
Anti-Platelet DrugsAnti-Platelet Drugs
• Thromboxane Synthesis Inhibitors
• Phosphodiesterase Inhibitors
• ADP Inhibitors
• Glycoprotein IIb/IIIa Inhibitors
![Page 245: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/245.jpg)
Thromboxane Synthesis Thromboxane Synthesis InhibitorsInhibitors• Irreversibly acetylates COX- inhibition
of TXA2 synthesis, lasts for 8 – 10 days
• Aspirin– primary prophylaxis for MI
– secondary prophylaxis for MI and stroke
![Page 246: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/246.jpg)
Phosphodiesterase InhibitorsPhosphodiesterase Inhibitors
• Dypiridamole– given together with antiplatelet;
ineffective when alone
– Inc CAMP
– SE: coronary steal phenomenon
![Page 247: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/247.jpg)
ADP Inhibitors - ADP Inhibitors - ThienopyridinesThienopyridines• Ticlopidine
– SE: thrombocytopenia purpura,neutropenia,
– n/v,diarrhea
• Clopidogrel– safer than ticlopidine
![Page 248: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/248.jpg)
Glycoprotein InhibitorsGlycoprotein Inhibitors
• Abciximab
• Eptifibatide
• Tirofiban
![Page 249: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/249.jpg)
Fibrinolytic AgentsFibrinolytic Agents
![Page 250: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/250.jpg)
Fibrinolytic Agents / Fibrinolytic Agents / ThrombolyticsThrombolytics• MOA
– catalyse activation of plasminogen to plasmin(serine protease)
• Use– mgt of severe pulmonary embolism– heart attack, acute MI,DVT
• Ex– Streptokinase – destroy fibrin that is either bound
to clots or is in the unbound form– Tissue plasminogen activator – binds to fibrin
bound to a clot– Anistreplase (APSAC)– Urokinase – from the kidneys
![Page 251: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/251.jpg)
Pro-coagulant DrugsPro-coagulant Drugs
![Page 252: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/252.jpg)
Pro-coagulant DrugsPro-coagulant Drugs
• Mgt of bleeding disorders– Vitamin K
• K1 – phytonadione (in plants, useful clinically)• K2 – menaquinone (intestinal bacteria)• K3 – menadione (synthetic)• used for Vit. K deficiency; hemorrhagic disorders in
newborns
– Aminocaproic Acid• prevents activation of plasminogen
– Tranexamic Acid (analogue)
• used to decrease risk of post surgery & post dental bleeding
![Page 253: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/253.jpg)
Drugs for DyslipidemiaDrugs for Dyslipidemia
![Page 254: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/254.jpg)
DyslipidemiaDyslipidemia
• Hypercholesterolemia (inc LDL, dec HDL)
• Hypertriglyceridemia (inc TG, ~ inc VLDL, chylomicrons)
• Liver– Only organ in the body that efficiently
uses cholesterol• Converts it to bile salts
![Page 255: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/255.jpg)
Cholesterol SynthesisCholesterol Synthesis
HMG-CoA Mevalonate Cholesterol
HMG-CoA Reductase
Cholesterol Source–Diet (exogenous)–Endogenous
hydroxymethylglutaryl- Coenzyme A (HMG-CoA)
![Page 256: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/256.jpg)
![Page 257: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/257.jpg)
AtherosclerosisAtherosclerosis
Condition associated with cholesterol deposition in vascular smooth muscles (arthroma) with consequent narrowing of the lumen of the affected blood vessels
![Page 258: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/258.jpg)
AtherosclerosisAtherosclerosis
• Could lead to…– CAD
– Cerebrovascular disease
– Aortic disease
– Renal artery disease
![Page 259: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/259.jpg)
AtherosclerosisAtherosclerosis
• Major Risk factors– Age (males: > 45;
females: > 55)– Smoking– DM– HPN– Dyslipidemia– Obesity– Family history of
premature heart attack
• Minor Risk Factors– Chronic infection– Sedentary lifestyle
• Modifiable Risk Factors– By therapy– By lifestyle change
![Page 260: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/260.jpg)
Drugs for DyslipidemiaDrugs for Dyslipidemia
• HMG-CoA Reductase Inhibitors
• Nicotinic Acid
• Bile Acid Sequesterants
• Fibric Acid Derivatives
• Probucol
![Page 261: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/261.jpg)
HMG-CoA Reductase HMG-CoA Reductase InhibitorsInhibitors• “-statins”
• MOA: inhibit the enzyme HMG-CoA Reductase, thereby inhibiting the first step (rate-limiting step) in cholesterol synthesis
• first-line drugs for dyslipidemia
![Page 262: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/262.jpg)
• Diurnal Pattern of Cholesterol Synthesis– means that the biosynthesis of
cholesterol in the body occurs at night
– thus most statins are given at bedtime (esp the short-acting ones)
HMG-CoA Reductase HMG-CoA Reductase InhibitorsInhibitors
![Page 263: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/263.jpg)
HMG-CoA Reductase HMG-CoA Reductase InhibitorsInhibitors• Short-acting
– simvastatin– lovastatin– fluvastatin
• Long-acting– atorvastatin– rosuvastatin Long-acting statins can
be given any time of the day.
![Page 264: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/264.jpg)
• SE:– hepatotoxicity
– myositis
– rhabdomyolysis (muscle wasting)
HMG-CoA Reductase HMG-CoA Reductase InhibitorsInhibitors
![Page 265: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/265.jpg)
![Page 266: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/266.jpg)
Nicotinic AcidNicotinic Acid
• unknown MOA
• used in the management of hypertriglyceridemia
• SE: flushing (due to percutaneous vasodilation), myositis
![Page 267: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/267.jpg)
Bile Acid SequesterantsBile Acid Sequesterants
• aka: Bile Acid – Binding Resins
• MOA: Inhibit reabsorption of bile acid
• since liver must maintain a certain amount of bile, it will synthesize bile from endogenous cholesterol when bile levels go low
![Page 268: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/268.jpg)
Bile Acid SequesterantsBile Acid Sequesterants
• Cholestyramine
• Colestipol
• SE:– constipation– impaired absorption of certain drugs– may increase incidence / risk of biliary
stone formation
![Page 269: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/269.jpg)
![Page 270: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/270.jpg)
![Page 271: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/271.jpg)
Fibric Acid DerivativesFibric Acid Derivatives
• MOA: stimulate lipoprotein lipase which decreases triglycerides
• first-line drug in hypertriglyceridemia
• Gemfibrozil• Fenofibrate• Clofibrate (withdrawn)
![Page 272: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/272.jpg)
Fibric Acid DerivativesFibric Acid Derivatives
• SE:– myositis
– rhabdomyolysis
– increase risk of bile stone formation
– hepatobiliary cancer (Clofibrate)
![Page 273: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/273.jpg)
ProbucolProbucol
• MOA: anti-oxidant
• SE: – increase risk of arrhythmia
– produces fetid odor
![Page 274: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/274.jpg)
Ok, before we end our Ok, before we end our lecture, quiz muna tayo… lecture, quiz muna tayo…
![Page 275: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/275.jpg)
Question 1:Question 1:
• Which enzyme is responsible for the conversion of Angiotensin I into the active form Angiotensin II?
A. Renin
B. ACE
C. HMG-CoA
D. StreptokinaseB
![Page 276: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/276.jpg)
Question 2:Question 2:• A 55 y/o male patient was diagnosed to
have uncomplicated HTN. Which of the following drugs would most likely be given to him?
A. Thiazide diuretic + Beta Blocker
B. ACE Inhibitor
C. CCB + ACE Inhibitor
D. ACEi + ARBA
![Page 277: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/277.jpg)
Question 3:Question 3:
• From the list of anti-hypertensive drugs below, select the one most likely to lower blood sugar:
A. Prazosin
B. Nifedipine
C. Propranolol
D. Hydralazine
E. Labetalol C
![Page 278: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/278.jpg)
Question 4:Question 4:
• Which of the following conditions predisposes a patient taking digitalis into arrhythmia?
A. hypocalcemia
B. decreased heart rate
C. hyponatremia
D. hypokalemia D
![Page 279: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/279.jpg)
Question 5:Question 5:
• All of the following mechanisms of action correctly match a drug, EXCEPT:
A. Quinidine: blocks Na+ channels
B. Bretylium: blocks K+ channels
C. Propranolol: blocks β-receptors
D. Procainamide: blocks K+ channelsD
![Page 280: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/280.jpg)
Question 6:Question 6:
• Which of the following adverse effects is associated with nitrates?
A. nausea
B. throbbing headache
C. sexual dysfunction
D. anemiaB
![Page 281: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/281.jpg)
Question 7:Question 7:
• A patient experienced orthostatic hypotension after taking the first dose of her drug. She most likely took:
A. Labetalol
B. Valdesartan
C. Prazosin
D. DigoxinC
![Page 282: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/282.jpg)
Question 8:Question 8:
• Mrs. G. R. is a hypertensive patient under therapy. After some time, she developed Lupus-like symptoms. Which of the ff drugs may have cause this?
A. Hydralazine
B. Losartan
C. Furosemide
D. Metoprolol A
![Page 283: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/283.jpg)
Question 9:Question 9:
• Which of the following antagonizes the co-factor functions of Vitamin K?
A. Tranexamic acid
B. Heparin
C. Warfarin
D. HirudinC
![Page 284: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/284.jpg)
Question 10:Question 10:
• The following drugs for dyslipidemia can cause rhabdomyolysis, EXCEPT:
A. simvastatin
B. atorvastatin
C. colestipol
D. fenofibrateC
![Page 285: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/285.jpg)
““The only thing greater The only thing greater than the power of the than the power of the
mind is the courage of the mind is the courage of the heart.”heart.”
- from the movie, - from the movie, A Beautiful MindA Beautiful Mind
![Page 286: Cvs drugs new](https://reader038.fdocuments.net/reader038/viewer/2022103000/554af0abb4c90559058b47cc/html5/thumbnails/286.jpg)